These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17223160)

  • 61. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
    Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and biological evaluation of new beta,beta'-disubstituted 6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl ethylamido melatoninergic ligands.
    Tsotinis A; Panoussopoulou M; Hough K; Sugden D
    Eur J Pharm Sci; 2003 Apr; 18(5):297-304. PubMed ID: 12694881
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design of subtype selective melatonin receptor agonists and antagonists.
    Sugden D; Yeh LK; Teh MT
    Reprod Nutr Dev; 1999; 39(3):335-44. PubMed ID: 10420436
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of putative melatonin receptor antagonists on melatonin-induced pigment aggregation in isolated Xenopus laevis melanophores.
    Sugden D
    Eur J Pharmacol; 1992 Mar; 213(3):405-8. PubMed ID: 1319920
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists.
    Mor M; Rivara S; Pala D; Bedini A; Spadoni G; Tarzia G
    Expert Opin Ther Pat; 2010 Aug; 20(8):1059-77. PubMed ID: 20533893
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design, synthesis, and melatoninergic activity of new azido- and isothiocyanato-substituted indoles.
    Tsotinis A; Afroudakis PA; Davidson K; Prashar A; Sugden D
    J Med Chem; 2007 Dec; 50(25):6436-40. PubMed ID: 17988084
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines.
    Garratt PJ; Jones R; Tocher DA; Sugden D
    J Med Chem; 1995 Mar; 38(7):1132-9. PubMed ID: 7707316
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mapping the melatonin receptor. 4. Comparison of the binding affinities of a series of substituted phenylalkyl amides.
    Garratt PJ; Travard S; Vonhoff S; Tsotinis A; Sugden D
    J Med Chem; 1996 Apr; 39(9):1797-805. PubMed ID: 8627603
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity.
    Spadoni G; Diamantini G; Bedini A; Tarzia G; Vacondio F; Silva C; Rivara M; Mor M; Plazzi PV; Zusso M; Franceschini D; Giusti P
    J Pineal Res; 2006 Apr; 40(3):259-69. PubMed ID: 16499563
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis of new melatoninergic hexahydroindenopyridines.
    Moreno L; Berenguer I; Diaz A; Marín P; Párraga J; Caignard DH; Figadère B; Cabedo N; Cortes D
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3534-6. PubMed ID: 24930835
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits.
    Alarma-Estrany P; Crooke A; Mediero A; Peláez T; Pintor J
    J Pineal Res; 2008 Nov; 45(4):468-75. PubMed ID: 18673419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design and synthesis of potent N1-substituted indole melatonin receptor agonists.
    Tsotinis A; Eleutheriades A; Hough K; Sugden D
    Chem Commun (Camb); 2003 Feb; (3):382-3. PubMed ID: 12613623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Melatonin receptor pharmacology: toward subtype specificity.
    Sugden D; Pickering H; Teh MT; Garratt PJ
    Biol Cell; 1997 Nov; 89(8):531-7. PubMed ID: 9618903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Melatonin analogues induce pigment granule condensation in isolated Xenopus laevis melanophores in tissue culture.
    Sugden D
    J Endocrinol; 1989 Jan; 120(1):R1-3. PubMed ID: 2918260
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice.
    Han J; Xu Y; Yu CX; Shen J; Wei YM
    Eur J Pharmacol; 2008 Oct; 594(1-3):125-31. PubMed ID: 18706407
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficient synthesis of hexahydroindenopyridines and their potential as melatoninergic ligands.
    Párraga J; Moreno L; Diaz A; El Aouad N; Galán A; Sanz MJ; Caignard DH; Figadère B; Cabedo N; Cortes D
    Eur J Med Chem; 2014 Oct; 86():700-9. PubMed ID: 25232966
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands.
    Attia MI; Güclü D; Hertlein B; Julius J; Witt-Enderby PA; Zlotos DP
    Org Biomol Chem; 2007 Jul; 5(13):2129-37. PubMed ID: 17581657
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Some sweet and bitter tastants stimulate inhibitory pathway of adenylyl cyclase via melatonin and alpha 2-adrenergic receptors in Xenopus laevis melanophores.
    Zubare-Samuelov M; Peri I; Tal M; Tarshish M; Spielman AI; Naim M
    Am J Physiol Cell Physiol; 2003 Nov; 285(5):C1255-62. PubMed ID: 12839835
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic potential of melatonin ligands.
    Delagrange P; Boutin JA
    Chronobiol Int; 2006; 23(1-2):413-8. PubMed ID: 16687314
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 4-Substituted anilides as selective melatonin MT2 receptor agonists.
    Epperson JR; Deskus JA; Gentile AJ; Iben LG; Ryan E; Sarbin NS
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1023-6. PubMed ID: 15013015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.